Live tape
Top 8, mentions 7d10,090GOOGL2,072 mentions▲ +0.04HTZ1,682 mentions▲ +0.10NBIS1,356 mentions▲ +0.10SPCX1,348 mentions▲ +0.08SNDK1,118 mentions▲ +0.11NVDA1,065 mentions▲ +0.08MSFT768 mentions▲ +0.06QQQ681 mentions▲ +0.08

Equity · Healthcare

CYDY

CytoDyn Inc. · OTC Markets OTCQB

Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for CYDY to draw a line in its place.

The chart above plots the price of CYDY over the range selected — one day to the full history — drawn by TradingView from their own data.

Filings 3 sets

CYDY reported financials

SEC EDGAR XBRL

CYDY reported net income of $3.7M for the fiscal year ended 31 May 2025.

Figure Reported Period
Net income $3.7M 31 May 2025 fiscal year
Diluted EPS $0.00 31 May 2025 fiscal year
Total assets $18.5M 28 Feb 2026 at period end
Total equity −$104.3M 28 Feb 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 28 Feb 2026

CYDY earnings

SEC EDGAR
Date Period EPS Revenue
28 Feb 2026 Q3 2026 $0.00
30 Nov 2025 Q2 2026 $-0.02
31 Aug 2025 Q1 2026 $0.00
31 May 2025 FY 2025 $0.00
28 Feb 2025 Q3 2025 $0.00
30 Nov 2024 Q2 2025 $0.00
31 Aug 2024 Q1 2025 $0.02
31 May 2024 FY 2024 $-0.05

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

CYDY fails-to-deliver

SEC CNS data

On 14 Jul 2026, 2,930,147 shares of CYDY failed to deliver (about $703K) — the latest of at least 7 consecutive trading days with recorded fails. The run reaches the start of the window we read, so it may have begun earlier.

Settlement date Shares failed Notional % of shares out
14 Jul 2026 2,930,147 $703K 0.215%
13 Jul 2026 2,479,955 $570K 0.182%
10 Jul 2026 2,869,239 $689K 0.210%
09 Jul 2026 3,322,513 $764K 0.243%
08 Jul 2026 2,886,654 $664K 0.211%
07 Jul 2026 2,393,154 $574K 0.175%
06 Jul 2026 2,569,112 $617K 0.188%

Source: SEC fails-to-deliver (CNS) data